$0.65 6.4%
BNGO Stock Price vs. AI Score (Last 150 days)
Data gathered: June 25

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Bionano Genomics

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight.


Bionano Genomics
Price $0.65
Target Price Sign up
Volume 1,200,000
Market Cap $52M
Year Range $0.65 - $2.1
Dividend Yield 0%
Revenue per Employee $79,321
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '248.4M26M-18M-31M-31M0.000
Q4 '235.9M31M-25M-44M-32M-0.959
Q3 '239.2M109M-99M-113M-112M-1.000
Q2 '238.6M33M-25M-39M-39M-1.240
Q1 '237.3M31M-24M-37M-37M-0.120

Insider Transactions View All

Mamuszka Hannah filed to buy 65,789 shares at $0.8.
June 14 '23
Holmlin R. Erik filed to buy 806,474 shares at $0.6.
May 16 '23
Stewart Christopher P. filed to buy 281,373 shares at $0.7.
May 16 '23
BARKER DAVID L filed to buy 13,894 shares at $1.6.
May 18 '22

What is the Market Cap of Bionano Genomics?

The Market Cap of Bionano Genomics is $52M.

How Many People Work at Bionano Genomics?

As of our latest update, Bionano Genomics employed approximately 405 people worldwide. However, it's important to note that Bionano Genomics' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Bionano Genomics' revenue per employee?

$79,321. To calculate Bionano Genomics' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Bionano Genomics?

Currently, the price of one share of Bionano Genomics stock is $0.65.

How can I analyze the BNGO stock price chart for investment decisions?

The BNGO stock price chart above provides a comprehensive visual representation of Bionano Genomics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bionano Genomics shares. Our platform offers an up-to-date BNGO stock price chart, along with technical data analysis and alternative data insights.

Does BNGO offer dividends to its shareholders?

As of our latest update, Bionano Genomics (BNGO) does not offer dividends to its shareholders. Investors interested in Bionano Genomics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Bionano Genomics?

Some of the similar stocks of Bionano Genomics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.